We have perionditis too at Phase 2A. Perhaps all our trials will be Phase 2A. No doubt TMJ and Concussion are coming this quarter after reading our expected expenditure of 300K for R&D for the quarter, which is coincidentally exactly the amount we pay for the 3M worth of trials, and we just got Linneas CBD Oils.
RespireRX already done a study on dronabinol for sleep apnea and are successful, moving into Phase 3. We are practically doing the same thing, just no one has done it in Aus yet.
Oy Vey, profit takers and day traders go on then, I'm chilling.
- Forums
- ASX - By Stock
- IHL
- Ann: Commencement of Phase 2a Sleep Apnoea Clinical Trial
Ann: Commencement of Phase 2a Sleep Apnoea Clinical Trial, page-14
-
- There are more pages in this discussion • 120 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IHL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online